This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Masuda, H. Articles by Hamilton, T. C. Search for Related Content PubMed PubMed Citation Articles by Masuda, H. Articles by Hamilton, T. C.

Increased DNA Repair as a Mechanism of Acquired Resistance to cis-Diamminedichloroplatinum(II) in Human Ovarian Cancer Cell Lines

Experimental Therapeutics Section, Medicine Branch, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland 20892

A human ovarian cancer cell line, A2780, derived from an untreated ovarian cancer patient and relatively sensitive to cisplatin was treated by stepwise incubation with cisplatin to produce a cisplatin-resistant variant, 2780^CP. The relative abilities of these cell lines to repair cisplatin-induced damage to cellular DNA then was examined by measure of [³H]thymidine incorporation into normal density DNA separated from bromodeoxyuridine-substituted DNA on alkaline cesium chloride gradients. These studies revealed that primary cisplatin resistance present in 2780^CP was associated with a near twofold-increased ability to repair damage induced by the drug under conditions where 2780^CP was approximately 5-fold resistant to cisplatin. Aphidicolin, a specific inhibitor of DNA polymerase , showed a dose-dependent capacity to inhibit DNA repair in this system with maximum inhibition of 63% at 4 µg/ml. It was also found that inhibition of DNA repair during and shortly after cisplatin exposure resulted in an approximately threefold increase in the cytotoxicity of cisplatin as monitored by clonogenic cell survival in the resistant but not the sensitive parental cell line.

¹ To whom requests for reprints should be addressed, at Medicine Branch, National Cancer Institute, Bldg. 10, Rm. 12N226, 9000 Rockville Pike, Bethesda, Maryland 20892.

Received 2/29/88. Revised 7/13/88. Accepted 7/18/88.

This article has been cited by other articles:

				E. Arimoto-Ishida, M. Ohmichi, S. Mabuchi, T. Takahashi, C. Ohshima, J. Hayakawa, A. Kimura, K. Takahashi, Y. Nishio, M. Sakata, et al. Inhibition of Phosphorylation of a Forkhead Transcription Factor Sensitizes Human Ovarian Cancer Cells to Cisplatin Endocrinology, April 1, 2004; 145(4): 2014 - 2022. [Abstract] [Full Text] [PDF]

				M. Selvakumaran, D. A. Pisarcik, R. Bao, A. T. Yeung, and T. C. Hamilton Enhanced Cisplatin Cytotoxicity by Disturbing the Nucleotide Excision Repair Pathway in Ovarian Cancer Cell Lines Cancer Res., March 15, 2003; 63(6): 1311 - 1316. [Abstract] [Full Text] [PDF]

				H. B. Deng, H. K. Parekh, K.-C. Chow, and H. Simpkins Increased Expression of Dihydrodiol Dehydrogenase Induces Resistance to Cisplatin in Human Ovarian Carcinoma Cells J. Biol. Chem., April 19, 2002; 277(17): 15035 - 15043. [Abstract] [Full Text] [PDF]

				T. Fojo Cancer, DNA Repair Mechanisms, and Resistance to Chemotherapy J Natl Cancer Inst, October 3, 2001; 93(19): 1434 - 1436. [Full Text] [PDF]

				T. Furuchi, H. Ishikawa, N. Miura, M. Ishizuka, K. Kajiya, S. Kuge, and A. Naganuma Two Nuclear Proteins, Cin5 and Ydr259c, Confer Resistance to Cisplatin in Saccharomyces cerevisiae Mol. Pharmacol., March 1, 2001; 59(3): 470 - 474. [Abstract] [Full Text]

				J. Hayakawa, M. Ohmichi, H. Kurachi, Y. Kanda, K. Hisamoto, Y. Nishio, K. Adachi, K. Tasaka, T. Kanzaki, and Y. Murata Inhibition of BAD Phosphorylation Either at Serine 112 via Extracellular Signal-regulated Protein Kinase Cascade or at Serine 136 via Akt Cascade Sensitizes Human Ovarian Cancer Cells to Cisplatin Cancer Res., November 1, 2000; 60(21): 5988 - 5994. [Abstract] [Full Text]

				Q. Li, K. Gardner, L. Zhang, B. Tsang, F. Bostick-Bruton, and E. Reed Cisplatin Induction of ERCC-1 mRNA Expression in A2780/CP70 Human Ovarian Cancer Cells J. Biol. Chem., September 4, 1998; 273(36): 23419 - 23425. [Abstract] [Full Text] [PDF]

				T. Yamada, R. Endo, M. Gotoh, and S. Hirohashi Identification of semaphorin E as a non-MDR drug resistance gene of human cancers PNAS, December 23, 1997; 94(26): 14713 - 14718. [Abstract] [Full Text] [PDF]

				J. J. Turchi and K. Henkels Human Ku Autoantigen Binds Cisplatin-damaged DNA but Fails to Stimulate Human DNA-activated Protein Kinase J. Biol. Chem., June 7, 1996; 271(23): 13861 - 13867. [Abstract] [Full Text] [PDF]